Abstract CT067: Preliminary safety and efficacy results of an anti-CD25 monoclonal antibody (BA1106) in patients with advanced solid tumors: The first-in-human study
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Peking University Cancer Hospital, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Affiliated Hospital of Jining Medical University, Jining Medical University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409822206
